论文信息 - Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod - 字舞流文

Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod

G. Tedeschi | A. Gallo | G. Donnarumma | M. Galdiero | A. Bisecco | R. Capuano | A. d’Ambrosio | M. Altieri | N. Coppola | E. Grimaldi | M. Conte | Nicola Medici | A. d'Ambrosio